New therapeutics consortium to bring focus to childhood cancer drug discovery and development

Cancer Research Horizons and LifeArc have joined forces to launch C-Further, an international consortium bringing together researchers, clinicians, drug developers and investors to create new children’s and young people’s cancer therapeutics.

With £28m in initial investment in resource and funding, C-Further offers researchers a comprehensive support package tailored to the unique needs of each project to help advance discoveries into therapeutics.

The consortium is looking for projects that have the potential to make an impact for children and young people with cancer.

Submit your research idea by the proposal deadline: 1 November 2024

CTA: Submit your proposal (https://bit.ly/4fWngtS)